MYFORTIC Side Effects

6655976-9 | Bronchospasm, Chest Discomfort, Dyspnoea, Influenza
on Mar 24, 2010 Male patient from BRAZIL , 49 years of age, weighting 143.3 lb, was diagnosed with pancreas transplant (What is pancreas transplant?) and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, chest discomfort, dyspnoea, influenza. Myfortic dosage: 360 Mg, Q8h. During the same period patient was treated with PROGRAF (1 Mg, 3 Capsules In The Morning And 2 Capsules At Night) (View Prograf Review and Prograf Label ), PREDNISONE (5 Mg, One Tablet In The Morning) (View Prednisone Review and Prednisone Label ).

6649518-1 | Diarrhoea, Haemodialysis, Renal Failure Acute
Patient was taking Myfortic (View Usage). Patient had the following side effects: diarrhoea, haemodialysis, renal failure acute on Mar 24, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 166.0 lb, was diagnosed with abdominal discomfort, hypomagnesaemia and. Myfortic dosage: 720 Mg Twice Daily Po. During the same period patient was treated with MAGNESIUM OXIDE 400 MG (400 Mg Twice Daily Po) (View Magnesium Oxide 400 Mg Review and Magnesium Oxide 400 Mg Label ), PROGRAF (View Prograf Review and Prograf Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), DAPSONE (View Dapsone Review and Dapsone Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), CALCIUM ELEMENTAL (View Calcium -elemental- Review and Calcium -elemental- Label ). Patient was hospitalized.

6645260-1 | Arteriosclerosis Coronary Artery, Bacterial Test Positive, Chest Pain, Clostridial Infection, Dyspnoea, Enterococcal Infection, Fatigue, Malaise, Oropharyngeal Pain
Adverse event was reported on Mar 12, 2010 by a Female patient taking Myfortic (View Usage) (Dosage: 720 Mg, Bid) was diagnosed with lung transplant (What is lung transplant?), immunosuppression, respiratory tract inflammation and. Location: UNITED STATES , weighting 108.0 lb, After Myfortic was administered, patient had the following side effects: arteriosclerosis coronary artery, bacterial test positive, chest pain (What is chest pain?), clostridial infection, dyspnoea, enterococcal infection, fatigue, malaise, oropharyngeal pain. During the same period patient was treated with AZITHROMYCIN (250 Mg, Qd) (View Azithromycin Review and Azithromycin Label ), PAXIL (20 Mg, Unk) (View Paxil Review and Paxil Label ), ATIVAN (1 Mg, Bid) (View Ativan Review and Ativan Label ), FISH OIL (1 G, Bid) (View Fish Oil Review and Fish Oil Label ), MYCELEX (1 Po Qid X 2 Weeks) (View Mycelex Review and Mycelex Label ), PRANDIN ^KUHN^ (0.5 Mg, Tid With Meals) (View Prandin ^kuhn^ Review and Prandin ^kuhn^ Label ), PROGRAF (2mg Am, 2.5 Mg Pm, Goal 10-12) (View Prograf Review and Prograf Label ). Patient was hospitalized.

6641360-0 | Circulatory Collapse, Guillain-barre Syndrome, Loss Of Consciousness, Quadriparesis, Respiratory Failure, Sedation
on Mar 14, 2010 Male patient from POLAND , weighting 119.0 lb, was diagnosed with renal transplant, immunosuppression and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, guillain-barre syndrome (What is guillain-barre syndrome?), loss of consciousness, quadriparesis, respiratory failure, sedation. Myfortic dosage: . During the same period patient was treated with PROGRAF (10 Mg, Unk) (View Prograf Review and Prograf Label ), ENCORTON (10 Mg, Unk) (View Encorton Review and Encorton Label ). Patient was hospitalized.


6639711-6 | Altered State Of Consciousness, Bronchitis, C-reactive Protein Increased, Chest Discomfort, Confusional State, Cough, Disorientation, Dizziness, Dyspnoea
on Mar 04, 2010 Male patient from GERMANY , 69 years of age, weighting 220.5 lb, was diagnosed with renal transplant, herpes zoster, hypertension and was treated with Myfortic (View Usage). Patient had the following side effects: altered state of consciousness, bronchitis (What is bronchitis?), c-reactive protein increased, chest discomfort, confusional state, cough, disorientation, dizziness (What is dizziness?), dyspnoea. Myfortic dosage: Unk. During the same period patient was treated with CARBAMAZEPINE (200 Mg, Bid) (View Carbamazepine Review and Carbamazepine Label ), TACROLIMUS (2.5 Mg, Qd) (View Tacrolimus Review and Tacrolimus Label ), VALTREX (1000 Mg, Tid) (View Valtrex Review and Valtrex Label ), METOHEXAL (47.5 Mg, Bid) (View Metohexal Review and Metohexal Label ). Patient was hospitalized.

6602110-7 | Agranulocytosis, Cytomegalovirus Infection
Patient was taking Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?) on Feb 16, 2010 from SPAIN Additional patient health information: Female patient , 40 years of age, was diagnosed with transplant rejection, cytomegalovirus infection (What is cytomegalovirus infection?) and. Myfortic dosage: 360 Mg, Bid. During the same period patient was treated with LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ), VALCYTE (450 Mg Daily) (View Valcyte Review and Valcyte Label ), CERTICAN (View Certican Review and Certican Label ), DACORTIN (Unk) (View Dacortin Review and Dacortin Label ), MERONEM (Unk) (View Meronem Review and Meronem Label ).

6596326-6 | Anaemia, Atrial Fibrillation, Headache, Heart Rate Irregular, Hypertension, Musculoskeletal Stiffness, Myalgia, Myoglobin Blood Increased
Adverse event was reported on Feb 15, 2010 by a Female patient taking Myfortic (View Usage) (Dosage: 360 Mg, Bid) was diagnosed with renal transplant and. Location: NETHERLANDS , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, atrial fibrillation (What is atrial fibrillation?), headache (What is headache?), heart rate irregular, hypertension, musculoskeletal stiffness, myalgia, myoglobin blood increased. During the same period patient was treated with ALEFACEPT (7.5 Mg) (View Alefacept Review and Alefacept Label ), PROGRAF (View Prograf Review and Prograf Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), VALCYTE (View Valcyte Review and Valcyte Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PREVACID (View Prevacid Review and Prevacid Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6586017-X | Blood Creatinine Increased, C-reactive Protein Increased, Cyst Drainage, Lymphocele, Seroma, Therapeutic Procedure, Ureteric Obstruction, Urethritis
on Feb 11, 2010 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient had the following side effects: blood creatinine increased, c-reactive protein increased, cyst drainage, lymphocele, seroma, therapeutic procedure, ureteric obstruction, urethritis. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with NEORAL (250 Mg, Bid) (View Neoral Review and Neoral Label ), PREDNISOLONE (20 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), NO TREATMENT RECEIVED NOMED (No Treatment) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ). Patient was hospitalized.

6586016-8 | Blood Creatinine Increased, C-reactive Protein Increased, Cyst Drainage, Lymphocele, Seroma, Therapeutic Procedure, Ureteric Obstruction, Urethritis
on Feb 11, 2010 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: blood creatinine increased, c-reactive protein increased, cyst drainage, lymphocele, seroma, therapeutic procedure, ureteric obstruction, urethritis. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with NEORAL (250 Mg, Bid) (View Neoral Review and Neoral Label ), PREDNISOLONE (20 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), NO TREATMENT RECEIVED NOMED (No Treatment) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ). Patient was hospitalized.

6578507-0 | Arteriovenous Fistula Operation, Post Procedural Complication, Renal Artery Thrombosis, Renal Pelvis Fistula
Patient was taking Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: arteriovenous fistula operation, post procedural complication, renal artery thrombosis, renal pelvis fistula on Feb 04, 2010 from GERMANY Additional patient health information: Male patient , weighting 146.6 lb, was diagnosed with renal transplant and. Myfortic dosage: Unk. During the same period patient was treated with SANDIMMUNE (Unk) (View Sandimmune Review and Sandimmune Label ), NO TREATMENT RECEIVED NOMED (No Treatment) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), DECORTIN (Unk) (View Decortin Review and Decortin Label ).

6537518-1 | Coagulopathy, Confusional State, Disorientation, Hallucination, Visual, Post Procedural Haemorrhage
Adverse event was reported on Jan 12, 2010 by a Male patient taking Myfortic (View Usage) (Dosage: 1440 Mg) was diagnosed with renal transplant and. Location: SPAIN , weighting 154.3 lb, Patient had the following side effects: coagulopathy, confusional state, disorientation, hallucination, visual, post procedural haemorrhage. During the same period patient was treated with TACROLIMUS (10 Mg) (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6534075-0 | Catheter Removal, Cystoscopy, Dizziness, Nausea, Ureteral Stent Removal
on Jan 07, 2010 Female patient from AUSTRALIA , weighting 116.8 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: catheter removal, cystoscopy, dizziness (What is dizziness?), nausea (What is nausea?), ureteral stent removal. Myfortic dosage: 500 Mg, Bid. During the same period patient was treated with CERTICAN (Unk) (View Certican Review and Certican Label ), CYCLOSPORINE (75 Mg, Bid) (View Cyclosporine Review and Cyclosporine Label ), STEROIDS NOS (Unk) (View Steroids Nos Review and Steroids Nos Label ). Patient was hospitalized.

6527609-3 | Bronchospasm, Chest Discomfort, Dyspnoea, Influenza
on Dec 29, 2009 Male patient from BRAZIL , 49 years of age, weighting 143.3 lb, was diagnosed with pancreas transplant (What is pancreas transplant?) and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, chest discomfort, dyspnoea, influenza. Myfortic dosage: 360 Mg, Q8h. During the same period patient was treated with PROGRAF (1 Mg, 3 Capsules In The Morning And 2 Capsules At Night) (View Prograf Review and Prograf Label ), PREDNISONE (5 Mg, One Tablet In The Morning) (View Prednisone Review and Prednisone Label ).

6524044-9 | Blood Creatinine Increased, Cytomegalovirus Infection, Diabetes Mellitus, Diarrhoea, Dyspepsia, Myocardial Ischaemia, Nausea, Nephropathy Toxic
Patient was taking Myfortic (View Usage). Patient had the following side effects: blood creatinine increased, cytomegalovirus infection (What is cytomegalovirus infection?), diabetes mellitus, diarrhoea, dyspepsia, myocardial ischaemia, nausea (What is nausea?), nephropathy toxic on Dec 22, 2009 from POLAND Additional patient health information: Male patient , weighting 130.1 lb, was diagnosed with renal transplant and. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with TACROLIMUS (12 Mg /24h) (View Tacrolimus Review and Tacrolimus Label ), ENCORTON (15 Mg/24h) (View Encorton Review and Encorton Label ). Patient was hospitalized.

6524042-5 | Dysphagia, Haematemesis, Oesophageal Stenosis, Oesophagitis
Adverse event was reported on Dec 28, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: 720 Mg/day) was diagnosed with systemic lupus erythematosus and. Location: SWITZERLAND , 46 years of age, After Myfortic was administered, patient had the following side effects: dysphagia, haematemesis, oesophageal stenosis, oesophagitis. Patient was hospitalized.

6523696-7 | Blood Creatinine Increased, Catheter Removal, Complications Of Transplanted Kidney, Debridement, Impaired Healing
on Dec 28, 2009 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, catheter removal, complications of transplanted kidney, debridement, impaired healing. Myfortic dosage: Unk. During the same period patient was treated with CERTICAN (Unk) (View Certican Review and Certican Label ), SANDIMMUNE (Unk) (View Sandimmune Review and Sandimmune Label ), URBASON (Unk) (View Urbason Review and Urbason Label ). Patient was hospitalized.

6522087-2 | Anaemia, Asthenia, Blood Sodium Decreased, Body Temperature Decreased, Complications Of Transplanted Kidney, Conjunctival Pallor, Cytomegalovirus Infection, Decreased Appetite
on Dec 18, 2009 Female patient from POLAND , weighting 125.7 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient had the following side effects: anaemia, asthenia, blood sodium decreased, body temperature decreased, complications of transplanted kidney, conjunctival pallor, cytomegalovirus infection (What is cytomegalovirus infection?), decreased appetite. Myfortic dosage: 1440 Mg/day. During the same period patient was treated with NEORAL (100 Mg/day) (View Neoral Review and Neoral Label ), ENCORTON (10 Mg) (View Encorton Review and Encorton Label ). Patient was hospitalized.

6505195-1 | Cardiac Failure Acute
Patient was taking Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: cardiac failure acute on Dec 14, 2009 from GERMANY Additional patient health information: Female patient , weighting 142.2 lb, was diagnosed with renal transplant and. Myfortic dosage: 360 Mg, Bid. During the same period patient was treated with SANDIMMUNE (30 Mg, Bid) (View Sandimmune Review and Sandimmune Label ), NO TREATMENT RECEIVED NOMED (30 Mg, Bid) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), URBASON (2 Mg, Qd) (View Urbason Review and Urbason Label ).

6505161-6 | Ocular Vasculitis, Renal Lymphocele, Uveitis, Visual Acuity Reduced
Adverse event was reported on Dec 11, 2009 by a Male patient taking Myfortic (View Usage) (Dosage: 720 Mg, Bid) was diagnosed with renal transplant and. Location: GERMANY , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: ocular vasculitis, renal lymphocele, uveitis, visual acuity reduced. During the same period patient was treated with SANDIMMUNE (100 Mg, Bid) (View Sandimmune Review and Sandimmune Label ), NO TREATMENT RECEIVED NOMED (Unk) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), DECORTIN H (12.5 Mg / Day) (View Decortin-h Review and Decortin-h Label ). Patient was hospitalized.

6498059-3 | Coagulopathy, Confusional State, Disorientation, Hallucination, Visual, Post Procedural Haemorrhage
on Dec 11, 2009 Male patient from SPAIN , weighting 154.3 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient had the following side effects: coagulopathy, confusional state, disorientation, hallucination, visual, post procedural haemorrhage. Myfortic dosage: 1440 Mg. During the same period patient was treated with TACROLIMUS COMP TAC+ (10 Mg) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6488009-8 | Catheter Removal, Cystoscopy, Dizziness, Nausea, Ureteral Stent Removal
on Dec 02, 2009 Female patient from AUSTRALIA , weighting 116.8 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: catheter removal, cystoscopy, dizziness (What is dizziness?), nausea (What is nausea?), ureteral stent removal. Myfortic dosage: 500 Mg, Bid. During the same period patient was treated with CERTICAN (Unk) (View Certican Review and Certican Label ), CYCLOSPORINE (75 Mg, Bid) (View Cyclosporine Review and Cyclosporine Label ), STEROIDS NOS (Unk) (View Steroids Nos Review and Steroids Nos Label ). Patient was hospitalized.

6475512-X | Cardiac Failure Acute
Patient was taking Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute on Nov 30, 2009 from GERMANY Additional patient health information: Female patient , weighting 142.2 lb, was diagnosed with renal transplant and. Myfortic dosage: 360 Mg, Bid. During the same period patient was treated with SANDIMMUNE (30 Mg, Bid) (View Sandimmune Review and Sandimmune Label ), NO TREATMENT RECEIVED NOMED (30 Mg, Bid) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), URBASON (2 Mg, Qd) (View Urbason Review and Urbason Label ).

6461860-6 | Anaemia, Asthenia, Blood Sodium Decreased, Body Temperature Decreased, Complications Of Transplanted Kidney, Conjunctival Pallor, Cytomegalovirus Infection, Decreased Appetite
Adverse event was reported on Nov 18, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: 1440 Mg/day) was diagnosed with renal transplant and. Location: POLAND , weighting 114.6 lb, Patient had the following side effects: anaemia, asthenia, blood sodium decreased, body temperature decreased, complications of transplanted kidney, conjunctival pallor, cytomegalovirus infection (What is cytomegalovirus infection?), decreased appetite. During the same period patient was treated with NEORAL (100 Mg/day) (View Neoral Review and Neoral Label ), ENCORTON (10 Mg) (View Encorton Review and Encorton Label ). Patient was hospitalized.

6457569-5 | Back Pain, Chills, Escherichia Urinary Tract Infection, Nephrectomy, Pyrexia
on Nov 17, 2009 Female patient from POLAND , weighting 127.9 lb, was diagnosed with immunosuppression and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: back pain (What is back pain?), chills, escherichia urinary tract infection, nephrectomy, pyrexia. Myfortic dosage: 1440 Mg/day. During the same period patient was treated with ENCORTON (10 Mg, Unk) (View Encorton Review and Encorton Label ), ADVAGRAF (5 Mg) (View Advagraf Review and Advagraf Label ). Patient was hospitalized.

6450536-7 | Blood Creatinine Increased, Catheter Removal, Complications Of Transplanted Kidney, Debridement, Impaired Healing
on Nov 12, 2009 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, catheter removal, complications of transplanted kidney, debridement, impaired healing. Myfortic dosage: Unk. During the same period patient was treated with RAD 666 RAD+TAB (Unk) (View Rad 666 Rad+tab Review and Rad 666 Rad+tab Label ), SANDIMMUNE (Unk) (View Sandimmune Review and Sandimmune Label ), URBASON (Unk) (View Urbason Review and Urbason Label ). Patient was hospitalized.

6450529-X | Blood Creatinine Increased, Catheter Removal, Complications Of Transplanted Kidney, Debridement, Impaired Healing
Patient was taking Myfortic (View Usage). Patient had the following side effects: blood creatinine increased, catheter removal, complications of transplanted kidney, debridement, impaired healing on Nov 12, 2009 from GERMANY Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with renal transplant and. Myfortic dosage: Unk. During the same period patient was treated with RAD 666 RAD+TAB (Unk) (View Rad 666 Rad+tab Review and Rad 666 Rad+tab Label ), SANDIMMUNE (Unk) (View Sandimmune Review and Sandimmune Label ), URBASON (Unk) (View Urbason Review and Urbason Label ). Patient was hospitalized.

6449465-4 | Coagulopathy, Confusional State, Disorientation, Hallucination, Visual, Post Procedural Haemorrhage
Adverse event was reported on Nov 18, 2009 by a Male patient taking Myfortic (View Usage) (Dosage: 1440 Mg) was diagnosed with renal transplant and. Location: SPAIN , weighting 154.3 lb, After Myfortic was administered, patient had the following side effects: coagulopathy, confusional state, disorientation, hallucination, visual, post procedural haemorrhage. During the same period patient was treated with TACROLIMUS COMP TAC+ (10 Mg) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6445416-7 | Arrhythmia, Palpitations, Ventricular Extrasystoles
on Nov 11, 2009 Male patient from GERMANY , weighting 171.5 lb, was diagnosed with renal transplant, hypertension, arrhythmia (What is arrhythmia?) and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), palpitations, ventricular extrasystoles. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with SANDIMMUNE (125 Mg, Bid) (View Sandimmune Review and Sandimmune Label ), NO TREATMENT RECEIVED NOMED (No Treatment Received) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), DECORTIN (Open Label) (View Decortin Review and Decortin Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6444802-9 | Anaemia, Cytomegalovirus Infection, Renal Impairment, Renal Tubular Disorder
on Nov 05, 2009 Female patient from POLAND , weighting 126.8 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient had the following side effects: anaemia, cytomegalovirus infection (What is cytomegalovirus infection?), renal impairment, renal tubular disorder. Myfortic dosage: 1440 Mg Daily. During the same period patient was treated with PROGRAF (14 Mg, Unk) (View Prograf Review and Prograf Label ), CALCORT (24 Mg, Unk) (View Calcort Review and Calcort Label ), CERTICAN (View Certican Review and Certican Label ). Patient was hospitalized.

6442993-7 | Escherichia Urinary Tract Infection, Nephrectomy
Patient was taking Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: escherichia urinary tract infection, nephrectomy on Nov 03, 2009 from POLAND Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with immunosuppression and. Myfortic dosage: . During the same period patient was treated with TACROLIMUS (4 Mg, Unk) (View Tacrolimus Review and Tacrolimus Label ), ENCORTON (10 Mg, Unk) (View Encorton Review and Encorton Label ). Patient was hospitalized.

6442108-5 | Haematotoxicity, Pancytopenia
Adverse event was reported on Nov 03, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: 1 G, Bid) was diagnosed with renal transplant and. Location: SPAIN , 74 years of age, Patient experienced the following unwanted or unexpected effects: haematotoxicity, pancytopenia. During the same period patient was treated with SEPTRIN (3 Divided Doses) (View Septrin Review and Septrin Label ), RAPAMUNE (2 Mg, Qd) (View Rapamune Review and Rapamune Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6440634-6 | Anaemia, Asthenia, Blood Sodium Decreased, Body Temperature Decreased, Complications Of Transplanted Kidney, Conjunctival Pallor, Cytomegalovirus Infection, Decreased Appetite, Hypothyroidism
on Nov 02, 2009 Female patient from POLAND , weighting 114.6 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient had the following side effects: anaemia, asthenia, blood sodium decreased, body temperature decreased, complications of transplanted kidney, conjunctival pallor, cytomegalovirus infection (What is cytomegalovirus infection?), decreased appetite, hypothyroidism. Myfortic dosage: 1440 Mg/day. During the same period patient was treated with NEORAL (Unk) (View Neoral Review and Neoral Label ), ENCORTON (Unk) (View Encorton Review and Encorton Label ). Patient was hospitalized.

6438314-6 | Blood Creatinine Increased, C-reactive Protein Increased, Cough, Diarrhoea, Dyspnoea, Encephalitis Viral, Genital Herpes, Herpes Zoster, Loss Of Consciousness
on Nov 06, 2009 Male patient from GERMANY , 64 years of age, weighting 167.6 lb, was diagnosed with renal transplant, immunosuppression, hypertension, renal osteodystrophy, cardiac failure and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: blood creatinine increased, c-reactive protein increased, cough, diarrhoea, dyspnoea, encephalitis viral, genital herpes, herpes zoster, loss of consciousness. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with PROGRAF (2 Mg, Bid) (View Prograf Review and Prograf Label ), AMLODIPINE (5 Mg, Bid) (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), DOCITON (10 Mg, Tid) (View Dociton Review and Dociton Label ), EINSALPHA (0.5 Ug, Qd) (View Einsalpha Review and Einsalpha Label ), LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6417295-5 | Arrhythmia, Palpitations, Ventricular Extrasystoles
Patient was taking Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), palpitations, ventricular extrasystoles on Oct 19, 2009 from GERMANY Additional patient health information: Female patient , weighting 171.5 lb, was diagnosed with renal transplant, hypertension, arrhythmia (What is arrhythmia?) and. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with SANDIMMUNE (125 Mg, Bid) (View Sandimmune Review and Sandimmune Label ), NO TREATMENT RECEIVED NOMED (Open Label) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), DECORTIN (Open Label) (View Decortin Review and Decortin Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6410966-6 | Axonal Neuropathy, Myalgia
Adverse event was reported on Oct 20, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: 720mg Bid Po) was diagnosed with renal transplant and. Location: UNITED STATES , 64 years of age, Patient had the following side effects: axonal neuropathy, myalgia. Patient was hospitalized.

6406314-8 | Anaemia, Asthenia, Blood Sodium Decreased, Conjunctival Pallor, Decreased Appetite, Feeling Cold, Hypothyroidism, Lip Oedema, Oral Fungal Infection
on Oct 08, 2009 Female patient from POLAND , weighting 114.6 lb, was diagnosed with renal transplant, hypothyroidism and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: anaemia, asthenia, blood sodium decreased, conjunctival pallor, decreased appetite, feeling cold, hypothyroidism, lip oedema, oral fungal infection. Myfortic dosage: 1440 Mg/day. During the same period patient was treated with NEORAL (Unk) (View Neoral Review and Neoral Label ), ENCORTON (Unk) (View Encorton Review and Encorton Label ), LETROX (75 Ug/day) (View Letrox Review and Letrox Label ). Patient was hospitalized.

6394847-2 | Aplastic Anaemia, Normochromic Normocytic Anaemia
on Oct 02, 2009 Male patient from UNITED STATES , weighting 130.1 lb, was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, normochromic normocytic anaemia. Myfortic dosage: Unk. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ).

6369071-X | Angina Pectoris, Blood Creatine Phosphokinase Increased, Coronary Artery Disease, Leukocytosis, Oedema Peripheral, Troponin Increased
Patient was taking Myfortic (View Usage). Patient had the following side effects: angina pectoris, blood creatine phosphokinase increased, coronary artery disease (What is coronary artery disease?), leukocytosis, oedema peripheral, troponin increased on Sep 14, 2009 from SPAIN Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with renal transplant and. Myfortic dosage: 540 Mg, Bid. During the same period patient was treated with TACROLIMUS COMP TAC+ (7 Mg, Bid) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ), TACROLIMUS COMP TAC+ (5 Mg, Bid) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ), PREDNISONE (20 Mg, Qd) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6367729-X | Diaphragmatic Hernia, Extracorporeal Membrane Oxygenation, Haemorrhage Neonatal, Mediastinal Shift, Polyhydramnios, Premature Baby, Pulmonary Hypoplasia
Adverse event was reported on Sep 15, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: Maternal Dose: 720 Mg Bid Po, 360 Mg Bid Po) . Location: UNITED STATES , weighting 4.50 lb, After Myfortic was administered, patient had the following side effects: diaphragmatic hernia, extracorporeal membrane oxygenation, haemorrhage neonatal, mediastinal shift, polyhydramnios, premature baby, pulmonary hypoplasia. During the same period patient was treated with PROGRAF (Maternal Dose: 3 Mg Bid Po, 3 Mg Bid Po, 2 Mg Bid Po, 3 Mg Bid Po) (View Prograf Review and Prograf Label ), PREDNISONE (Maternal Dose: 10 Mg Qd Po) (View Prednisone Review and Prednisone Label ), DAPSONE (Unk) (View Dapsone Review and Dapsone Label ), CELEXA (Maternal Dose: 20 Mg Qd Po) (View Celexa Review and Celexa Label ), THYROXIN (Maternal Dose: 0.5 Mg Qd Po) (View Thyroxin Review and Thyroxin Label ), VALCYTE (Maternal Dose: 450 Mg Qd Po, 450 Mg Qod Po) (View Valcyte Review and Valcyte Label ), METOPROLOL TARTRATE (Maternal Dose: 25 Mg Qd Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CONTRACEPTIVES NOS (View Contraceptives Nos Review and Contraceptives Nos Label ). Patient was hospitalized.

6367727-6 | Abortion Spontaneous
on Sep 15, 2009 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Myfortic dosage: 180 Mg, Bid. During the same period patient was treated with PROGRAF (4 Mg Am, 5 Mg Pm) (View Prograf Review and Prograf Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), PRAVACHOL (Unk) (View Pravachol Review and Pravachol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

6367717-3 | Polyhydramnios
on Sep 15, 2009 Female patient from UNITED STATES , weighting 115.0 lb, was diagnosed with renal transplant and was treated with Myfortic (View Usage). Patient had the following side effects: polyhydramnios. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with PROGRAF (3 Mg, Bid) (View Prograf Review and Prograf Label ), PREDNISONE (10 Mg, Qd) (View Prednisone Review and Prednisone Label ), DAPSONE (View Dapsone Review and Dapsone Label ), CELEXA (20 Mg, Qd) (View Celexa Review and Celexa Label ).

6341926-1 | Polyhydramnios
Patient was taking Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: polyhydramnios on Aug 25, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 115.0 lb, was diagnosed with renal transplant and. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with PROGRAF (3 Mg, Bid) (View Prograf Review and Prograf Label ), PREDNISONE TAB (10 Mg, Qd) (View Prednisone Tab Review and Prednisone Tab Label ), DAPSONE (View Dapsone Review and Dapsone Label ), CELEXA (20 Mg, Qd) (View Celexa Review and Celexa Label ).

6341913-3 | Abortion Spontaneous
Adverse event was reported on Aug 25, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: 180 Mg, Bid) was diagnosed with heart transplant (What is heart transplant?) and. Location: UNITED STATES , weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: abortion spontaneous. During the same period patient was treated with PROGRAF (4 Mg Am, 5 Mg Pm) (View Prograf Review and Prograf Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), PRAVACHOL (Unk) (View Pravachol Review and Pravachol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

6336232-5 | Blood Creatinine Increased, Cytomegalovirus Infection, Diarrhoea, Gastritis, Nausea, Oesophagitis
on Aug 24, 2009 Male patient from POLAND , weighting 238.1 lb, was diagnosed with immunosuppression, gout (What is gout?) and was treated with Myfortic (View Usage). Patient had the following side effects: blood creatinine increased, cytomegalovirus infection (What is cytomegalovirus infection?), diarrhoea, gastritis, nausea (What is nausea?), oesophagitis. Myfortic dosage: 720 Mg, Bid. During the same period patient was treated with MILURIT (300 Mg, Unk) (View Milurit Review and Milurit Label ). Patient was hospitalized.

6334846-X | Diaphragmatic Hernia, Extracorporeal Membrane Oxygenation, Haemorrhage Neonatal, Mediastinal Shift, Polyhydramnios, Premature Baby, Pulmonary Hypoplasia
on Aug 25, 2009 Female patient from UNITED STATES , weighting 4.50 lb, was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: diaphragmatic hernia, extracorporeal membrane oxygenation, haemorrhage neonatal, mediastinal shift, polyhydramnios, premature baby, pulmonary hypoplasia. Myfortic dosage: Maternal Dose: 720 Mg Bid Po, 360 Mg Bid Po. During the same period patient was treated with PROGRAF (Maternal Dose: 3 Mg Bid Po, 3 Mg Bid Po, 2 Mg Bid Po, 3 Mg Bid Po) (View Prograf Review and Prograf Label ), PREDNISONE TAB (Maternal Dose: 10 Mg Qd Po) (View Prednisone Tab Review and Prednisone Tab Label ), DAPSONE (Unk) (View Dapsone Review and Dapsone Label ), CELEXA (Maternal Dose: 20 Mg Qd Po) (View Celexa Review and Celexa Label ), THYROXIN (Maternal Dose: 0.5 Mg Qd Po) (View Thyroxin Review and Thyroxin Label ), VALCYTE (Maternal Dose: 450 Mg Qd Po, 450 Mg Qod Po) (View Valcyte Review and Valcyte Label ), METOPROLOL (Maternal Dose: 25 Mg Qd Po) (View Metoprolol Review and Metoprolol Label ), CONTRACEPTIVES NOS (View Contraceptives Nos Review and Contraceptives Nos Label ). Patient was hospitalized.

6301684-3 | Cough, Infarction, Malaise, Syncope
Patient was taking Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: cough, infarction, malaise, syncope on Aug 05, 2009 from BRAZIL Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with prophylaxis against transplant rejection, blood pressure increased and. Myfortic dosage: 3 Tablets Daily. During the same period patient was treated with ENALAPRIL MALEATE (2 Tablets Daily) (View Enalapril Maleate Review and Enalapril Maleate Label ), RENAGEL (3 Tablets Daily) (View Renagel Review and Renagel Label ), ATENOLOL (2 Tablets Daily) (View Atenolol Review and Atenolol Label ), LOSARTAN POTASSIUM (2 Tablets Daily) (View Losartan Potassium Review and Losartan Potassium Label ), PREDNISONE (2 Tablets Daily) (View Prednisone Review and Prednisone Label ), FUROSEMIDE (1 Tablet Daily) (View Furosemide Review and Furosemide Label ), OMEPRAZOL (2 Tablets Daily) (View Omeprazol Review and Omeprazol Label ).

6294858-1 | Leukopenia, Proteinuria, Splenomegaly, Thrombocytopenia
Adverse event was reported on Jul 28, 2009 by a Female patient taking Myfortic (View Usage) (Dosage: 1080 Mg/day) was diagnosed with systemic lupus erythematosus, hypertension, diabetes mellitus and. Location: GERMANY , weighting 147.7 lb, Patient had the following side effects: leukopenia, proteinuria, splenomegaly, thrombocytopenia. During the same period patient was treated with QUENSYL (400mg/d) (View Quensyl Review and Quensyl Label ), TENORMIN (37.25mg/d) (View Tenormin Review and Tenormin Label ), AMARYL (6 Mg/d) (View Amaryl Review and Amaryl Label ), PREDNISOLONE (10mg/d) (View Prednisolone Review and Prednisolone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOL (View Omeprazol Review and Omeprazol Label ), DIGITOXIN TAB (0.07) (View Digitoxin Tab Review and Digitoxin Tab Label ). Patient was hospitalized.

6291565-6 | Deep Vein Thrombosis, Pulmonary Embolism
on Jul 27, 2009 Male patient from SPAIN , 73 years of age, was diagnosed with myasthenia gravis and was treated with Myfortic (View Usage). After Myfortic was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Myfortic dosage: Unk. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

6291551-6 | Deep Vein Thrombosis, Pulmonary Embolism
on Jul 27, 2009 Male patient from SPAIN , 86 years of age, was diagnosed with myasthenia gravis and was treated with Myfortic (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Myfortic dosage: 360 Mg, Q12h. During the same period patient was treated with LOSARTAN POTASSIUM (50 Mg Daily) (View Losartan Potassium Review and Losartan Potassium Label ), PREDNISONE TAB (20mg A Day And 40mg The Following Day) (View Prednisone Tab Review and Prednisone Tab Label ), MESTINON (1 Df, Q8h) (View Mestinon Review and Mestinon Label ), UROTROL (4 Mg Daily) (View Urotrol Review and Urotrol Label ), OMEPRAZOL (20 Mg Daily) (View Omeprazol Review and Omeprazol Label ), CALCIUM SANDOZ FORTE (2 Df, Qd) (View Calcium-sandoz Forte Review and Calcium-sandoz Forte Label ), SERETIDE (Unk) (View Seretide Review and Seretide Label ), LOBIVON (1/2 Tablet Every Morning) (View Lobivon Review and Lobivon Label ). Patient was hospitalized.

6290924-5 | Cytomegalovirus Infection, Headache, Hyperhidrosis, Hypertensive Heart Disease, Kidney Transplant Rejection, Pain In Extremity, Pyrexia, Renal Failure Chronic
Patient was taking Myfortic (View Usage). Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), headache (What is headache?), hyperhidrosis, hypertensive heart disease, kidney transplant rejection, pain in extremity, pyrexia, renal failure chronic on Jul 22, 2009 from GERMANY Additional patient health information: Female patient , 50 years of age, weighting 116.8 lb, was diagnosed with renal transplant, hypertension, osteoporosis (What is osteoporosis?) and. Myfortic dosage: 360 Mg, Qid. During the same period patient was treated with PROGRAF (3 Mg, Bid) (View Prograf Review and Prograf Label ), PREDNISOLONE (15 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), AMLODIPINE (5 Mg, Bid) (View Amlodipine Review and Amlodipine Label ), AMPHOTERICIN B (10 Mg, Qid) (View Amphotericin B Review and Amphotericin B Label ), METOPROLOL SUCCINATE (23.75 Mg, Bid) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CALCIMAGON D3 (1 Df, Bid) (View Calcimagon-d3 Review and Calcimagon-d3 Label ), DELIX (2.5 Mg, Qd) (View Delix Review and Delix Label ). Patient was hospitalized.